Big movements in Biolife Sciences Inc stock price on Thursday moving 56.91% between high and low

The Biolife Sciences Inc stock price gained 44.72% on the last trading day (Thursday, 30th Dec 2021), rising from $0.92 to $1.33. , and has now gained 7 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the day the stock fluctuated 56.91% from a day low at $0.86 to a day high of $1.35. The price has risen in 7 of the last 10 days and is up by 99.4% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 824 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $2.37 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled.Given the current short-term trend, the stock is expected to rise 87.79% during the next 3 months and, with a 90% probability hold a price between $1.28 and $4.52 at the end of this 3-month period.

The Biolife Sciences Inc stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $0.81 and $1.08. A breakdown below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, December 06, 2021, and so far it has fallen -36.67%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

On the downside, the stock finds support just below today's level from accumulated volume at $1.26 and $1.18.There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Biolife Sciences Inc finds support just below today's level at $1.26. If this is broken, then the next support from accumulated volume will be at $1.18 and $1.17.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.49 between high and low, or 56.91%. For the last week, the stock has had a daily average volatility of 28.08%.

Since the Biolife Sciences Inc has been rising for 7 days in a row, the risk over the next couple of days has increased. We don't expect a major reaction as the stock is in very good shape technically, and therefore hold a positive evaluation despite the very short term risk.

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Biolife Sciences Inc stock to perform well in the short-term.We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.